Methods for prognosing the status of tumor patients

Details for Australian Patent Application No. 2009218461 (hide)

Owner Thurnher, M.

Inventors Ramoner, Reinhold; Thurnher, Martin

Agent Davies Collison Cave

Pub. Number AU-A-2009218461

PCT Pub. Number WO2009/106579

Priority 08450024.8 28.02.08 EP; 08450080.0 15.05.08 EP

Filing date 26 February 2009

Wipo publication date 3 September 2009

International Classifications

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/14 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from fungi, algae or lichens

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/106579 Priority application(s): WO2009/106579

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009218462-Method for identifying inhibitors against viruses that use a class I fusion protein

2009218460-Use of SIP1 as determinant of breast cancer stemness